Apoptosis by 2-chloro-2'-deoxy-adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells

Neurochemistry International

Volumn 32, Issue 5-6, 1998, Pages 493-504

  Barbieri, D ^a   Abbracchio, M P ^b   Salvioli, S ^a   Monti, D ^a   Cossarizza, A ^a   Ceruti, S ^b   Brambilla, R ^b   Cattabeni, F ^b   Jacobson, K A ^c   Franceschi, C ^a,d  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d INRCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLOROADENOSINE; 5 IODOTUBERCIDIN; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; CLADRIBINE; DIPYRIDAMOLE; DNA FRAGMENT; RECEPTOR SUBTYPE;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DIPLOIDY; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

2-CHLOROADENOSINE; ADENOSINE; APOPTOSIS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CLADRIBINE; DIPYRIDAMOLE; ENZYME INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MITOCHONDRIA; MONOCYTES; NUCLEOSIDES; RECEPTORS, PURINERGIC P1; TUBERCIDIN; TUMOR CELLS, CULTURED;

EID: 0032078729     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(97)00129-0     Document Type: Article

References (43)

1. Abbracchio, M.P., Ceruti, S., Barbieri, D., Franceschi, C., Malorni, W., Biondo, L., Burnstock, G., Cattabeni, F., 1995. A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem. Biophys. Res. Commun. 213, 908-915.
2. 3 receptor. Annals N.Y. Acad. Sci., 825, 11-22.
3. Abeles, R.H., Tashjian, A.H., Jr., Fish, S., 1980. The mechanisms of inactivation of S-adenosylhomocysteinase by 2′-deoxyadenosine. Biochem. Biophys. Res. Commun. 95, 612-617.
4. Barbieri, D., Grassilli, E., Monti, D., Salvioli, S., Franceschini, M.G., Franchini, A., Bellesia, E., Salomoni, P., Negro, P., Capri, M., Troiano, L., Cossarizza, A., Franceschi, C., 1994. D-ribose and deoxy-D-ribose induce apoptosis in human quiescent peripheral blood mononuclear cells. Biochem. Biophys. Res. Commun. 201, 1109-1116.
5. Beutler, E., 1992. Cladribine (2-chlorodeoxyadenosine). Lancet 340, 952-956.
6. Boyum, A., 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Lab. Invest. 21, Suppl. 97, 77-89.
7. Bryson, H.M., Sorkin, E.M., 1993. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignancies. Drugs 46, 872-894.
8. Carson, D.A., Wasson, D.B., Beutler, E., 1984. Antileukemic and immunosuppressive activity of 2-chloro-2′deoxyadenosine. Proc. Natl. Acad. Sci. U.S.A. 81, 2232-2236.
9. Carson, D.A., Wasson, D.B., Kaye, J., Ullman, B., Martin Jr, D.W., Robins, R.K., Montgomery, J.A., 1980. Deoxycytidine kinase-mediated toxicity of deoxyadenosine analogs toward malignant human lymphoblasts in vitro and toward murine L1210 leukemia in vivo. Proc. Natl. Acad. Sci. U.S.A. 77, 6865-6869.
10. Ceruti, S., Barbieri, D., Veronese, E., Cattabeni, F., Cossarizza, A., Giammarioli, A.M., Malorni, W., Franceschi, C., Abbracchio, M.P., 1997. Different pathways of apoptosis revealed by 2-chloroadenosine and deoxy-D-ribose in mammalian astroglial cells. J. Neurosci. Res. 47, 372-383.
11. Cheson, B.D., 1995. Infectious and immunosuppressive complications of purine analog therapy. J. Clin. Oncol. 13, 2431-2448.
12. Cohen, A., Hirschhorn, R., Horowitz, S.D., Rubinstein, A., Palmar, S.H., Hong, R., Martin, D.W. Jr., 1978. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc. Natl. Acad. Sci. U.S.A. 75, 471-476.
13. Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G., Franceschi, C., 1993. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′, 6,6′-tetrachloro-1,1′, 3,3′-tetraethylbenzimidazol-carbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun. 197, 40-45.
14. Cossarizza, A., Kalashnikova, G., Grassilli, E., Chiappelli, F., Salvioli, S., Capri, M., Barbieri, D., Troiano, L., Monti, D., Franceschi, C., 1994. Mitochondrial modifications during rat thymocyte apoptosis: a study at the single cell level. Exp. Cell Res. 214, 323-330.
15. Cossarizza, A., Franceschi, C., Monti, D., Salvioli, S., Bellesia, E., Rivabene, R., Biondo, L., Rainaldi, G., Tinari, A., Malorni, W., 1995a. Protective effect of N-acetylcysteine in tumor necrosis factor-α-induced apoptosis in U937 cells: the role of mitochondria. Exp. Cell Res. 220, 232-240.
16. Cossarizza, A., Salvioli, S., Franceschini, M.G., Kalashnikova, G., Barbieri, D., Monti, D., Grassilli, E., Tropea, F., Troiano, L., Franceschi, C., 1995b. Mitochondria and apoptosis: a cytofluorimetric approach. Fund. Clin. Immunol. 3, 67-68.
17. Dunwiddie, T.V., Abbracchio, M.P., Bischofberger, N., Brundege, J.M., Buell, G., Collo, G., Corsi, C., Diao, L., Kawashima, E., Jacobson, K.A., Latini, S., Lin, R.C.S., North, R.A., Pazzagli, M., Pedata, F., Pepeu, G.C., Proctor, W.R., Rassendren, F., Surprenant, A., Cattabeni, F., 1996. Purinoceptors in the central nervous system. Drug Dev. Res. 39, 361-370.
18. Fabianowska-Majewska, K., Tybor, K., Duley, J., Simmonds, A., 1995. The influence of 2-chloro-2′-deoxyadenosine on metabolism of deoxyadenosine in human primary CNS lymphoma. Biochem. Pharmacol. 50, 1379-1383.
19. Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Daly, J.W., Harden, T.K., Jacobson, K.A., Leff, P., Williams, M., 1994 VI. Nomenclature and Classification of Purinoceptors. Pharmacol. Rev. 46, 143-156.
20. Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Dubyak, G.R., Harden, K., Jacobson, K.A., Schwabe, U., Williams, M., 1997. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci. 18, 79-82.
21. Gao, X., Knudsen, T.B., Ibrahim, M.M., Haldar, S., 1995. Bcl-2 relieves deoxyadenylate stress and suppresses apoptosis in pre-B leukemia cells. Cell Death Differ. 2, 69-78.
22. Geiger, J.D., Fyda, D., 1991. Adenosine transport in the CNS. In Stone, T. (Ed.), Adenosine in the nervous system. Academic Press, San Diego, pp. 1-23.
23. Giblett, E.T., Anderson, J.R., Cohen, F., Pollara, B., Meuwissen, H.J., 1972. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 2, 1067-1069.
24. Gorski, A., Grieb, P., 1994. Cladribine (2-chloro-2′-deoxyadenosine): new perspectives in clinical immunosoppression. Arch. Immunol. Ther. Exp., Warsz 42, 11-12.
25. Jarvis, S.M., Martin, B.W., Ng, A.S., 1985. 2-chloro-adenosine: a permeant for the nucleoside transporter. Biochem. Pharmacol. 34, 3237-3241.
26. Kerr, J.F.R., Harmon, B.V., 1991. In Tomei, L.D., Cope, P.O. (Eds), Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory Press, New York, pp. 5-29.
27. Klotz, K.-N., Hessling, J., Hegler, J., Owman, C., Kull, B., Fredholm, B.B., Lohse, M.J., 1998. Comparative pharmacology of human adenosine receptor subtypes - Characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol., 357, 1-9.
28. 3 receptor agonists. Biochem. Biophys. Res. Commun. 219, 904-910.
29. 2A receptors. Drug Dev. Res. 39, 450-460.
30. Petit, P., Loubatieres-Mariani, N.M., Keppens, S., Sheehan, M.J., 1996. Purinergic receptors and metabolic function. Drug Dev. Res. 39, 413-425.
31. 2) receptor selective agonists. Int. J. Immunopharmacol. 17, 221-224.
32. Proctor, R.A., Denlinger, L.C., Leventhal, P.S., Daugherty, S.K., van de Loo, J.-W., Tanke, T., Firestein, G.S., Bertics, P.J., 1994. Protection of mice from endotoxic death by 2-methylthio-ATP. Proc. Natl. Acad. Sci. U.S.A. 91, 6017-6020.
33. Ribeiro, J.A., de Mendonca, A., Correia-de-Sa', P., Cunha, R.A., Sebastiao, A.M., 1996. Purinoceptors and synaptic plasticity. Drug Dev. Res. 39, 353-360.
34. Richter, C., Schweizer, M., Cossarizza, A., Franceschi, C., 1996. Control of apoptosis by the cellular ATP level. FEBS Letters 378, 107-110.
35. Robertson, L.E., Chubb, S., Meyn, R.E., Story, M., Ford, R., Hittelman, W.N., Plunkett, W., 1993. Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-β-D-arabinosyl-2-fluoroadenine. Blood 81, 143-150.
36. Sasvari-Szekely, M., Piroth, Zs., Kazimierczuk, Z., Staub, M., 1994. A novel effect of the new antileukemic drug, 2-chloro-2′-deoxyadenosine, in human lymphocytes. Biochem. Biophys. Res. Commun. 203, 1378-1384.
37. Seto, S., Carrera, C.J., Kubota, M., Wasson, D.B., Carson, D.A., 1985. Mechanism of deoxyadenosine and 2′-chloroadenosine toxicity to non-dividing human lymphocytes. J. Clin. Invest. 75, 377-383.
38. 3 receptors. J. Clin. Invest. 98, 1773-1779.
39. 2+-mediated mechanisms. Biochem. J. 304, 877-885.
40. Szondy, Z., 1995. The 2-chlorodeoxyadenosine-induced cell death signalling pathway in human thymocytes is different from that induced by 2-chloroadenosine. Biochem. J. 311, 585-588.
41. 2 receptors, adenosine inhibits the production of tumor necrosis factor-α of endotoxin-stimulated human polymorphonuclear leukocytes. J. Lab. Clin. Med. 126, 275-282.
42. Wood, A.J.J., 1994. New purines analogues for the treatment of hairy-cell leukemia. N. Engl. J. Med. 330, 691-697.
43. 3 antagonists. Biochem. Biophys. Res. Commun. 232, 317-322.